Advertisements


From Zit to Zip: Valeant Rises on Acne Drug Application

Valeant is rising on news that the FDA accepted the application of one of its acne drugs, with an approval decision date set for August......»»

Category: blogSource: barronsJan 12th, 2018

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to........»»

Category: blogSource: 247wallstDec 21st, 2017

Allergan/Paratek"s Acne Candidate NDA Filing Accepted by FDA

Allergan (AGN) and partner Paratek announces that its new drug application for Seysara has been .....»»

Category: smallbizSource: nytDec 21st, 2017

Allergan marketing application for acne drug accepted by FDA

Allergan PLC shares ticked higher in th.....»»

Category: topSource: marketwatchDec 20th, 2017

Alkermes Rallies as FDA Accepts NDA for Depression Drug

Shares of Alkermes (ALKS) rose when the FDA accepted for review the new drug application for its depre.....»»

Category: worldSource: nytApr 17th, 2018

Wall Street rises as Syria fears ease; healthcare stocks jump

(Reuters) - U.S. stocks rose on Monday on waning fears that the weekend's U.S.-led missile attack on Syria would escalate into a broader conflict and a rise in healthcare shares after Merck's positive update on a cancer drug......»»

Category: topSource: reutersApr 16th, 2018

Alkermes jumps 21% to $51.40 after FDA accepts depression drug application

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Alkermes"s stock soars after FDA accepts NDA review, 2 weeks after refusing

Shares of Alkermes PLC soared 21% in premarket trade Monday, after the biopharmaceutical company said the Food and Drug Administration accepted for review the company's new drug application (NDA) for.....»»

Category: topSource: marketwatchApr 16th, 2018

Catalyst (CPRX) Up on New Drug Application for Firdapse

Catalyst (CPRX) new drug applicati.....»»

Category: worldSource: nytApr 5th, 2018

Alkermes execs say they’re flummoxed by embarrassing FDA drug refusal; stock plunges

The regulator said it wouldn’t even review the company’s depression drug application, saying there wasn’t enough evidence that it worked......»»

Category: topSource: marketwatchApr 3rd, 2018

Dr Reddy"s files new drug application for migraine spray with USFDA

Upon approval, the product will be commercialised by Promius Pharma.....»»

Category: topSource: business-standardApr 2nd, 2018

Catalyst Pharmaceuticals files new drug application with FDA

Catalyst Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration, bringing the Coral Gables-based drug maker one step closer to launching Firdapse, a treatment for a rare degenerative neuromuscular disease. .....»»

Category: topSource: bizjournalsMar 29th, 2018

Cosmo application represents potential Valeant competition, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 20th, 2018

Catalyst (CPRX) Posts In-Line Q4 Loss, Pipeline in Progress

Catalyst Pharma (CPRX) reports in-line fourth-quarter 2017 loss and is on track to resubmit its new drug application for Firdapse in the first quarter of 201.....»»

Category: personnelSource: nytMar 15th, 2018

Valeant: Pfizer"s Ulcerative Colitis Drug Could Sting

Valeant: Pfizer"s Ulcerative Colitis Drug Could Sting.....»»

Category: topSource: seekingalphaMar 15th, 2018

Adamas stock rises 5% on strong launch of Parkinson"s drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 12th, 2018

Sarepta Therapeutics plans NDA of Duchenne MD treatment by year end

Shares of Sarepta Therapeutics Inc. surged 4.9% in premarket trade Monday, after the biopharmaceutical company said it planned to submit a New Drug Application (NDA) for its Duchenne muscular dystrophy treatmen.....»»

Category: topSource: marketwatchMar 12th, 2018

TherapeuticsMD announces FDA acceptance of TX-001HR new drug application

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 8th, 2018

Torrent gets favourable order against Otsuka"s patent application

The order is latest among the several battles both the companies took on related to the drug aripiprazole and its various forms.....»»

Category: topSource: business-standardMar 6th, 2018

Dermira Inc Stock Plunges on Acne Drug Failure

InvestorPlace - Stock M.....»»

Category: topSource: investorplaceMar 6th, 2018

Menlo Park drug maker scraps acne drug after $65M investment, shares plunge 66%

The company, with about a half-billion dollars in the bank, has one other drug being considered for FDA approval and another making its way through a mid-stage trial.....»»

Category: topSource: bizjournalsMar 5th, 2018